Article Text

Download PDFPDF
IDDF2024-ABS-0377 Investigation report on endoscopic management of esophagogastric variceal bleeding in portal hypertension in Southern China
  1. Yanrou Chen1,
  2. Yanping Liang2,
  3. Yunxiao Liang3,
  4. Feihu Bai4,
  5. Bin Wu2,
  6. Xing Wang2
  1. 1Zhongshan Medical School, Sun Yat-Sen University, Guangzhou, China
  2. 2Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
  3. 3Department of Gastroenterology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
  4. 4Department of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China

Abstract

Background Esophagogastric variceal bleeding (EGVB) is a severe complication of liver cirrhosis, and modern endoscopic strategies have been recommended as first-line. However, the prevention and treatment of gastric varices and special types of varices remain challenging tissues. In recent years, upper digestive tract hemorrhage in liver cirrhosis has significantly increased in the Southern China area. We investigate the current situation of the use of EGVB in portal hypertension in the Southern China area.

Methods We carried out an online questionnaire survey to investigate the use of endoscopic therapies for EGVB in Guangdong Province, Guangxi Zhuang Autonomous Region, and Hainan Province. Questions included the annual number of procedures, endoscopic choices for preventing EGVB, management of acute EGVB, fundamental treatment of cirrhosis-derived portal hypertension, and the follow-up of endoscopic therapies. Comparisons of guideline adherence among hospitals in different regions were performed using Chi-square or Fisher’s exact test when appropriate.

Results A total of 81 hospitals participated in the study. The survey showed that the leading indication of endoscopic therapies was treating acute EGVB (60.5%). For primary and secondary prophylaxis of EGVB, adherence to the national guidelines was 55.6%, and no significant differences in adherence were observed among different provinces (P=0.976 and 0.186, respectively). As much as 92.6% of hospitals preferred endoscopic therapies treating acute EGVB, and most of the hospitals carried out emergency endoscopies within 12~24 hours after the presentation of bleeding (82.7%). In the treatment of various types of gastric varices and ectopic varices, cyanoacrylate injection-based procedures (including cyanoacrylate injection alone or in combination with sclerotherapy) were the most prevalent procedures. 81.5% of hospitals routinely used non-selective beta-blockers for cirrhosis-derived portal hypertension, and the main drugs were propranolol (80.2%) and carvedilol (19.8%).

Conclusions Various endoscopic procedures for EGVB treatment have been conducted in Southern China. Participating hospitals are active in performing emergency endoscopies for acute EGVB. However, they are inadequate in following recommendations regarding primary and secondary prophylaxis of EGVB. It is necessary to standardize endoscopic indications further according to different types of varices and improve guideline compliance in the future.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.